<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/2072-0351-5581</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-6498</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Роль бета-клеток в регуляции гомеостаза глюкозыв норме и при сахарном диабете 2 типа</article-title><trans-title-group xml:lang="en"><trans-title>Rol' beta-kletok v regulyatsii gomeostaza glyukozyv norme i pri sakharnom diabete 2 tipa</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аметов</surname><given-names>Александр Сергеевич</given-names></name><name name-style="western" xml:lang="en"><surname>Ametov</surname><given-names>Alexander Sergeevich</given-names></name></name-alternatives><email xlink:type="simple">-</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ГОУ ВПО Российская медицинская академия последипломного образования, Москва</institution></aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>15</day><month>12</month><year>2008</year></pub-date><volume>11</volume><issue>4</issue><issue-title>№4 (2008)</issue-title><fpage>6</fpage><lpage>11</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Аметов А.С., 2008</copyright-statement><copyright-year>2008</copyright-year><copyright-holder xml:lang="ru">Аметов А.С.</copyright-holder><copyright-holder xml:lang="en">Ametov A.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/6498">https://www.dia-endojournals.ru/jour/article/view/6498</self-uri><abstract><p>В последние годы основные усилия ученых были сконцентрированы на изучении островковых клеток поджелудочной железы. Было установлено, что поджелудочная железа у человека содержит от 1 до 3 млн островковых клеток, что составляет около 1% от общей массы панкреатической ткани. В свою очередь, островковая клетка является самостоятельным органом, предназначенным для производства и секреции инсулина в необходимое время и в необходимых количествах.</p></abstract><kwd-group xml:lang="ru"><kwd>?-клетка</kwd><kwd>гомеостаз глюкозы</kwd><kwd>сахарный диабет 2 типа</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Barg S., Elliason L., Renstrom E. et al. A subject of 50 secretory granules in close contact with a-type Са2+ channels accounts for first-phase insulin secretion in mouse p-sells. Kinetics of insulin release in health and Type 2 Diabetes. Diabetes, 2002, February, V. 51, suppl. I, p. 74.</mixed-citation><mixed-citation xml:lang="en">Barg S., Elliason L., Renstrom E. et al. A subject of 50 secretory granules in close contact with a-type Са2+ channels accounts for first-phase insulin secretion in mouse p-sells. Kinetics of insulin release in health and Type 2 Diabetes. Diabetes, 2002, February, V. 51, suppl. I, p. 74.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bernard-Kargar C. Endocrine pancreas plasticity under physiological condi tions. Birth, Life and Death of a p-cell in Type 2 Diabetes. Diabetes, 2001, February, V. 50, suppl. 1, 30.</mixed-citation><mixed-citation xml:lang="en">Bernard-Kargar C. Endocrine pancreas plasticity under physiological condi tions. Birth, Life and Death of a p-cell in Type 2 Diabetes. Diabetes, 2001, February, V. 50, suppl. 1, 30.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bonner-Weir S. p-cell turnover: its assessment and implications. Birth, Life and Death of a p-cell in Type 2 Diabetes. Diabetes, 2001, February, V. 50, suppl. 1, 20.</mixed-citation><mixed-citation xml:lang="en">Bonner-Weir S. p-cell turnover: its assessment and implications. Birth, Life and Death of a p-cell in Type 2 Diabetes. Diabetes, 2001, February, V. 50, suppl. 1, 20.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bratanova-Tochkova T. K., Cheng H., Daniel S. et al. Triggering and argumentation mechanisms granule pools and biphasic insulin secretion. Kinetics of insulin release in health and Type 2 Diabetes. Diabetes, 2002, February, V. 51, suppl. 1, p. 83.</mixed-citation><mixed-citation xml:lang="en">Bratanova-Tochkova T. K., Cheng H., Daniel S. et al. Triggering and argumentation mechanisms granule pools and biphasic insulin secretion. Kinetics of insulin release in health and Type 2 Diabetes. Diabetes, 2002, February, V. 51, suppl. 1, p. 83.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Cerasi E. Type 2 Diabetes: To stimulate or not to stimulate the p-cell. Metabolism Clinical and Experimental, 2000, v. 49, 10, suppl. 2, 1-3.</mixed-citation><mixed-citation xml:lang="en">Cerasi E. Type 2 Diabetes: To stimulate or not to stimulate the p-cell. Metabolism Clinical and Experimental, 2000, v. 49, 10, suppl. 2, 1-3.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">De Fronzo R. Pharmacologic therapy for type 2 diabetes mellitus. Ann. Intern. Med., 1999, 131, 281-303.</mixed-citation><mixed-citation xml:lang="en">De Fronzo R. Pharmacologic therapy for type 2 diabetes mellitus. Ann. Intern. Med., 1999, 131, 281-303.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Del Prato S., Marchetti P. and bonadonna R. C. Phasic insulin release and metabolism regulation in Type 2 Diabetes. Kinetics of insulin release in health and Type 2 Diabetes. Diabetes, 2002, February, V. 51, suppl. 1, p. 109.</mixed-citation><mixed-citation xml:lang="en">Del Prato S., Marchetti P. and bonadonna R. C. Phasic insulin release and metabolism regulation in Type 2 Diabetes. Kinetics of insulin release in health and Type 2 Diabetes. Diabetes, 2002, February, V. 51, suppl. 1, p. 109.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Fajans S. Maturity-onset diabetes of the young (MODY). Diabetes Metab. Rev., 1989, 5, 579-606.</mixed-citation><mixed-citation xml:lang="en">Fajans S. Maturity-onset diabetes of the young (MODY). Diabetes Metab. Rev., 1989, 5, 579-606.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Henquin J.-C, Boitard C, Efendic S. et al. Insulin Secretion movement at all levels. Kinetics of insulin release in health and Type 2 Diabetes. Diabetes, 2002, February, V. 51, suppl. 1, p. 1.</mixed-citation><mixed-citation xml:lang="en">Henquin J.-C, Boitard C, Efendic S. et al. Insulin Secretion movement at all levels. Kinetics of insulin release in health and Type 2 Diabetes. Diabetes, 2002, February, V. 51, suppl. 1, p. 1.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hotamisligil G. Mechanisms of TNT-a-inducted insulin resistance. Experiment. And Clinical Endocrine, 1999, 107, 110-125.</mixed-citation><mixed-citation xml:lang="en">Hotamisligil G. Mechanisms of TNT-a-inducted insulin resistance. Experiment. And Clinical Endocrine, 1999, 107, 110-125.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kloppel G. et al. Islet pathology and pathogenesis of type 1 and type 2 diabetes revisited. Surv. Synth. Pathol. Res., 1985, 4, 110-125.</mixed-citation><mixed-citation xml:lang="en">Kloppel G. et al. Islet pathology and pathogenesis of type 1 and type 2 diabetes revisited. Surv. Synth. Pathol. Res., 1985, 4, 110-125.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lang et al. N. Engl. J. Med. 1979. 301, 1023. LJht. Diabetes Mellitus. Theory and Practice. Third Edition. Max Ellenberg, Harold Rifkin, 1983.</mixed-citation><mixed-citation xml:lang="en">Lang et al. N. Engl. J. Med. 1979. 301, 1023. LJht. Diabetes Mellitus. Theory and Practice. Third Edition. Max Ellenberg, Harold Rifkin, 1983.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Malaisse W. On the track of the beta-cell. Endocrine moiety. Diabetologia, 2001, 4, 44.</mixed-citation><mixed-citation xml:lang="en">Malaisse W. On the track of the beta-cell. Endocrine moiety. Diabetologia, 2001, 4, 44.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Olefsky J. Insulin resistance in non-insulin-dependent diabetes mellitus. Current option in Endocrinol. And Diabetes, 1995, 2, 290-299.</mixed-citation><mixed-citation xml:lang="en">Olefsky J. Insulin resistance in non-insulin-dependent diabetes mellitus. Current option in Endocrinol. And Diabetes, 1995, 2, 290-299.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Polonsky K. Abnormal patterns of insulin secretion in non-insulindependent diabetes mellitus. N. Engl. J. Med., 1988, 318, 1231- 1239.</mixed-citation><mixed-citation xml:lang="en">Polonsky K. Abnormal patterns of insulin secretion in non-insulindependent diabetes mellitus. N. Engl. J. Med., 1988, 318, 1231- 1239.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Polonsky K. Alternations in immunoreactive proinsulin and insulin clearance inducted by weight loss in NIDDM. Diabetes, 1994, 43, 871- 877.</mixed-citation><mixed-citation xml:lang="en">Polonsky K. Alternations in immunoreactive proinsulin and insulin clearance inducted by weight loss in NIDDM. Diabetes, 1994, 43, 871- 877.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Reaven G.M. Plasma insulin, C-peptide and proinsulin concentrations inobese and non-obese individuals with varying degrees of glucose intolerance. J. Clin. Endocrinol. and Metabolism, 1993, 76, 44-48.</mixed-citation><mixed-citation xml:lang="en">Reaven G.M. Plasma insulin, C-peptide and proinsulin concentrations inobese and non-obese individuals with varying degrees of glucose intolerance. J. Clin. Endocrinol. and Metabolism, 1993, 76, 44-48.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
